High blood pressure is a leading modifiable risk factor cardiovascular disease (CVD) mortality which is why controlling this has become such a big focus for so many healthcare providers. The US currently uses a treat-to-target strategy. Europe on the other hand uses a benefit-based, tailored treatment strategy in which therapy is initiated for patients with high estimated CVD risk. Both of these emphasize that the goal of controlling blood pressure is not to lower it but to avoid CVD events. The team in this study used models to simulate adults ages 30 to 70 in divers populations. The study had three groups, the US method, the European method, and a hybrid of the two.
It turns out that the study showed that the treat-to-target would be the best model to use in both China and India to allow for the most decrease in risk for CVD related events. Less people would be treated under the other system although treatment strategies would be similar.
Basu S, Yudkin JS, Sussman JB, Millett C, and Hayward RA. Alternative strategies to achieve cardiovascular mortality goals in china and india. Circulation. 2016;133:840-48.